Glatiramer
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Glatiramer Acetate is a generic prescription drug manufactured by Mylan Pharmaceuticals Inc. It is a 40 mg/mL solution administered via subcutaneous injection and is used to treat relapsing forms of multiple sclerosis by reducing the frequency of relapses. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Glatiramer
Access the FDA dataset for Glatiramer — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025